24 May 2013
Keywords: medimmune, asthma, drug, enters, ph, ii, drugmaker
Article | 05 May 2008
US drugmaker MedImmune says it has advanced the development of CAT-354, its potential treatment for asthma, with the start of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
5 May 2008
23 May 2013
© 2013 thepharmaletter.com